Differential Genetic and Epigenetic Regulation of catechol-O-methyltransferase is Associated with Impaired Fear Inhibition in Posttraumatic Stress Disorder

The catechol-O-methyltransferase (COMT) enzyme is critical for the catabolic regulation of synaptic dopamine, resulting in altered cortical functioning. The COMT Val158Met polymorphism has been implicated in human mental illness, with Met/Met homozygotes associated with increased susceptibility to posttraumatic stress disorder (PTSD). Our primary objective was to examine the intermediate phenotype of fear inhibition in PTSD stratified by COMT genotype (Met/Met, Val/Met, and Val/Val) and differential gene regulation via methylation status at CpG sites in the COMT promoter region. More specifically, we examined the potential interaction of COMT genotype and PTSD diagnosis on fear-potentiated startle during fear conditioning and extinction and COMT DNA methylation levels (as determined using genomic DNA isolated from whole blood). Participants were recruited from medical and gynecological clinics of an urban hospital in Atlanta, GA, USA. We found that individuals with the Met/Met genotype demonstrated higher fear-potentiated startle to the CS− (safety signal) and during extinction of the CS+ (danger signal) compared to Val/Met and Val/Val genotypes. The PTSD+ Met/Met genotype group had the greatest impairment in fear inhibition to the CS− (p = 0.006), compared to Val carriers. In addition, the Met/Met genotype was associated with DNA methylation at four CpG sites, two of which were associated with impaired fear inhibition to the safety signal. These results suggest that multiple differential mechanisms for regulating COMT function – at the level of protein structure via the Val158Met genotype and at the level of gene regulation via differential methylation – are associated with impaired fear inhibition in PTSD.

[1]  K. Lesch,et al.  Children under stress - COMT genotype and stressful life events predict cortisol increase in an acute social stress paradigm. , 2012, The international journal of neuropsychopharmacology.

[2]  A. Veronica Witte,et al.  Effects of COMT polymorphisms on brain function and behavior in health and disease , 2012, Brain Research Bulletin.

[3]  B. Bradley,et al.  Estrogen Levels Are Associated with Extinction Deficits in Women with Posttraumatic Stress Disorder , 2012, Biological Psychiatry.

[4]  R. Dobson,et al.  Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood , 2012, Genome Biology.

[5]  Kerry J. Ressler,et al.  PTSD and gene variants: New pathways and new thinking , 2012, Neuropharmacology.

[6]  J. Kwon,et al.  Influence of brain-derived neurotrophic factor and catechol O-methyl transferase polymorphisms on effects of meditation on plasma catecholamines and stress , 2012, Stress.

[7]  B. Bradley,et al.  Attention bias toward threat is associated with exaggerated fear expression and impaired extinction in PTSD , 2011, Psychological Medicine.

[8]  T. Jovanović,et al.  Neural Mechanisms of Impaired Fear Inhibition in Posttraumatic Stress Disorder , 2011, Front. Behav. Neurosci..

[9]  Leonardo Fazio,et al.  Stress-Related Methylation of the Catechol-O-Methyltransferase Val158 Allele Predicts Human Prefrontal Cognition and Activity , 2011, The Journal of Neuroscience.

[10]  K. Lesch,et al.  Variation in genes involved in dopamine clearance influence the startle response in older adults , 2011, Journal of Neural Transmission.

[11]  B. Bradley,et al.  Fear Extinction in Traumatized Civilians with Posttraumatic Stress Disorder: Relation to Symptom Severity , 2011, Biological Psychiatry.

[12]  Q. Cordeiro,et al.  Catechol-O-methyltransferase (COMT) val158met Polymorphism as a Risk Factor for PTSD After Urban Violence , 2011, Journal of Molecular Neuroscience.

[13]  A. Meyer-Lindenberg,et al.  Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis , 2010, Molecular Psychiatry.

[14]  B. Bradley,et al.  Fear potentiation is associated with hypothalamic–pituitary–adrenal axis function in PTSD , 2010, Psychoneuroendocrinology.

[15]  Kerry J Ressler,et al.  How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. , 2010, The American journal of psychiatry.

[16]  Ming D. Li,et al.  Determination of Methylated CpG Sites in the Promoter Region of Catechol-O-Methyltransferase (COMT) and their Involvement in the Etiology of Tobacco Smoking , 2010, Front. Psychiatry.

[17]  B. Bradley,et al.  Impaired fear inhibition is a biomarker of PTSD but not depression , 2010, Depression and anxiety.

[18]  Stephan Kolassa,et al.  The Risk of Posttraumatic Stress Disorder After Trauma Depends on Traumatic Load and the Catechol-O-Methyltransferase Val158Met Polymorphism , 2010, Biological Psychiatry.

[19]  K. Ressler,et al.  Genetics of anxiety and trauma-related disorders , 2009, Neuroscience.

[20]  A. Amstadter,et al.  Genetics of PTSD: Fear Conditioning as a Model for Future Research. , 2009, Psychiatric annals.

[21]  Michael Davis,et al.  Posttraumatic stress disorder may be associated with impaired fear inhibition: Relation to symptom severity , 2009, Psychiatry Research.

[22]  Alfons O. Hamm,et al.  Genetic Gating of Human Fear Learning and Extinction , 2009, Psychological science.

[23]  C. Montag,et al.  COMT genetic variation affects fear processing: psychophysiological evidence. , 2008, Behavioral neuroscience.

[24]  Yuchiao Chang,et al.  Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. , 2008, Journal of psychiatric research.

[25]  K. Ressler,et al.  Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. , 2008, JAMA.

[26]  B. Kolachana,et al.  COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET , 2008, Molecular Psychiatry.

[27]  S. Galea,et al.  The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. , 2007, The American journal of psychiatry.

[28]  K. Koenen.  Genetics of posttraumatic stress disorder: Review and recommendations for future studies. , 2007, Journal of traumatic stress.

[29]  Eric J. Nestler,et al.  Epigenetic regulation in psychiatric disorders , 2007, Nature Reviews Neuroscience.

[30]  Andreas Meyer-Lindenberg,et al.  Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. , 2006, Archives of general psychiatry.

[31]  S. Faraone,et al.  Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. , 2006, Human molecular genetics.

[32]  Michael Davis,et al.  Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm. , 2006, Learning & memory.

[33]  Saša Virijević Jovanović,et al.  Contingency awareness and fear inhibition in a human fear-potentiated startle paradigm. , 2006, Behavioral neuroscience.

[34]  George C Patton,et al.  Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health , 2005, Psychiatric genetics.

[35]  Shiva M. Singh,et al.  Site‐specific cytosine methylation in S‐COMT promoter in 31 brain regions with implications for studies involving schizophrenia , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[36]  Andreas Heinz,et al.  Catechol-O-Methyltransferase val158met Genotype Affects Processing of Emotional Stimuli in the Amygdala and Prefrontal Cortex , 2005, The Journal of Neuroscience.

[37]  M. Egan,et al.  Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.

[38]  A. Grace,et al.  The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes , 2004, Neuropsychopharmacology.

[39]  Young-Hee Choi,et al.  The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. , 2004, Journal of psychiatric research.

[40]  Paul J. Harrison,et al.  Catechol-O-Methyltransferase Inhibition Improves Set-Shifting Performance and Elevates Stimulated Dopamine Release in the Rat Prefrontal Cortex , 2004, The Journal of Neuroscience.

[41]  S. Faraone,et al.  Methylomics in psychiatry: Modulation of gene–environment interactions may be through DNA methylation , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[42]  J. Korf,et al.  Lymphocytes as a neural probe: potential for studying psychiatric disorders , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  Paul J. Harrison,et al.  Catechol‐o‐methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression , 2004, Synapse.

[44]  David Goldman,et al.  Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism , 2003, Psychiatric genetics.

[45]  B. Lipska,et al.  Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function , 2003, Neuroscience.

[46]  A. Sampson,et al.  Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization , 2001, The Journal of comparative neurology.

[47]  D. Pfaff,et al.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Allan I. Levey,et al.  Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter , 1998, The Journal of Neuroscience.

[49]  E. Tunbridge.  The catechol-O-methyltransferase gene: its regulation and polymorphisms. , 2010, International review of neurobiology.

[50]  J. Stockman.  Association of FKBP5 Polymorphisms and Childhood Abuse With Risk of Posttraumatic Stress Disorder Symptoms in Adults , 2009 .

[51]  Michael Davis,et al.  Timing of extinction relative to acquisition: a parametric analysis of fear extinction in humans. , 2008, Behavioral neuroscience.

[52]  Andreas Heinz,et al.  The Effects of Catechol O-methyltransferase Genotype on Brain Activation Elicited by Affective Stimuli and Cognitive Tasks , 2006, Reviews in the neurosciences.